Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-19T07:22:26.230Z Has data issue: false hasContentIssue false

Stimulant medication in 47,XYY syndrome: a report of two cases

Published online by Cambridge University Press:  14 July 2005

Anne Ruud
Affiliation:
Sorlandet Resource Centre, Norway.
Peter Arnesen
Affiliation:
Sorlandet Resource Centre, Norway.
Liv Larsen Stray
Affiliation:
Sorlandet Resource Centre, Norway.
Stéphane Vildalen
Affiliation:
Department of Child Psychiatry, Sorlandet Hospital, Kristiansand, Norway.
Per Vesterhus
Affiliation:
Department of Paediatrics, Sorlandet Hospital, Kristiansand, Norway.
Get access

Abstract

In two males, 11 and 12 years of age, referred for attention-deficit–hyperactivity disorder (ADHD), 47,XYY syndrome was diagnosed. A team that included a neuropsychologist, a physiotherapist, and a physician examined them. Stature (patients were above 97.5% height for age), muscle consistency, and tremor indicated chromosome analysis. Psychological tests results did not fully fit the ADHD diagnosis. On the basis of our clinical observation we felt that stimulant medication was indicated. Administration of methylphenidate led to improved motor and cognitive functions as well as social adaptation in both patients. We suggest that this treatment might well be considered in clinically similar patients with XYY sex chromosomes; we further suggest that learning problems in such individuals may be related to ADHD.

Type
Case Report
Copyright
© 2005 Mac Keith Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)